Clinical Trial Update: A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase II study update for HR070803 in advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• HR070803

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Advanced Esophageal Cancer | Phase 2 | Status: UNKNOWN